Smooth Drug Development – Performs a bioequivalence study
Published on Friday September 13, 2013

Performs a new bioequivalence study

Smooth Drug Development performs a bioequivalence study of a fixed dose combination of two antiretroviral drugs.

Clinics selected by us meet strict requirements to providers of bioequivalence trials and have the most modern equipment. Reports are prepared in accordance with latest requirements of the Ministry of Health of the Russian Federation.

Smooth partners with a leading clinical research site. Approximate timelines of a trial are 3 months from clinical trial authorization to clinical study report.

Our team perform bioequivalence trials in patients and special populations.